**Question:** Mechanism of action of cephalosporin is:

A. Inhibition of bacterial cell wall synthesis
B. Inhibition of bacterial protein synthesis
C. Inhibition of bacterial DNA synthesis
D. Inhibition of bacterial RNA synthesis

**Core Concept:**
Cephalosporins are a class of antibiotics that primarily target Gram-positive and some Gram-negative bacteria by inhibiting bacterial cell wall synthesis. They are structurally similar to penicillins, but have additional hydroxyl groups at the C3 position, which increases their spectrum of activity.

**Why the Correct Answer is Right:**
Cephalosporins work by binding to penicillin-binding proteins (PBPs), which are essential for the synthesis of bacterial cell walls. This binding leads to the inhibition of transpeptidation and transglycosylation reactions, ultimately resulting in the inhibition of cell wall synthesis and the death of the bacteria.

**Why Each Wrong Option is Incorrect:**
A. Bacterial cell wall synthesis inhibition is the correct mechanism for cephalosporins, not inhibition of bacterial protein synthesis. Protein synthesis occurs in the cytoplasm and is not directly related to cephalosporin action.

B. Cephalosporins do not inhibit bacterial protein synthesis, as they target the cell wall synthesis, not the ribosomes involved in protein synthesis.

C. Cephalosporins primarily affect Gram-positive bacteria, not bacterial DNA synthesis, which is unrelated to their mechanism of action.

D. Cephalosporins do not inhibit bacterial RNA synthesis, as they target cell wall synthesis, not RNA synthesis.

**Clinical Pearl:**
Understanding the mechanism of action of cephalosporins is crucial for selecting the appropriate antibiotic therapy in clinical settings, particularly for treating infections caused by Gram-positive organisms like Staphylococcus aureus or Streptococcus pneumoniae. Cephalosporins are less effective against Gram-negative bacteria due to the outer membrane barrier and the presence of beta-lactamase enzymes. Penicillins and carbapenems are more effective alternatives for Gram-negative infections.